Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $1.05 Trillion |
|---|---|
| Enterprise Value | $1.04 Trillion |
| Annual dividend | $7.00 |
| Dividend yield | 0.38% |
| Earnings per Share | $60.34 |
| Beta | 0.02 |
| Outstanding Shares | 575,400,000 |
| P/E Ratio | 26.44 |
|---|---|
| PEG | 80.8 |
| Price to Sales | 2.85 |
| Price to Book Ratio | 2.67 |
| Enterprise Value to Revenue | 2.81 |
| Enterprise Value to EBIT | 17.09 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.22 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Aurobindo Pharma Limited is a global pharmaceutical company specializing in the production of generic formulations and active pharmaceutical ingredients (APIs). Its operations span across India, the United States, Europe, and other inter...